From: Neuropathic pain in a sample of Egyptian patients with rheumatoid arthritis
Characteristics | RA patients with neuropathic pain (n = 14) | RA patients without neuropathic pain (n = 98) | P value |
---|---|---|---|
Sex | Â | Â | 0.687 |
 Male | 1 (7.1%) | 8 (8.2%) | |
 Female | 13 (92.9%) | 90 (91.8%) | |
Age | 49 ± 7.75 | 44.27 ± 10.29 | 0.101 |
Education level | Â | Â | 0.898 |
 No formal education | 9 (64.3%) | 65 (66.3%) | |
 Primary education | 3 (21.4%) | 14 (14.3%) |  |
 Secondary education | 1 (7.1%) | 10 (10.2%) |  |
 Tertiary education | 1 (7.1%) | 9 (9.2%) |  |
Disease duration (years) | 11.21 ± 1.67 | 4.66 ± 1.47 | 0.001 |
RF (IU/mL) | Â | Â | Â |
 Positive | 11 (78.6%) | 70 (71.4%) | 0.754 |
 Negative | 3 (21.4%) | 28 (28.6%) | |
Anti-CCP (u/ml) | Â | Â | Â |
 Positive | 7 (50%) | 58 (59.2%) | 0.515 |
 Negative | 7 (50%) | 40 (40.8%) | |
VAS (0–100 mm) | 7.36 ± 1.34 | 1.91 ± 1.08 | < 0.001 |
DAS-28 score | 5.27 ± 0.82 | 2.33 ± 0.71 | < 0.001 |
HAQ | 1.19 ± 0.41 | 0.26 ± 0.27 | < 0.001 |
BMI (kg/m2) | 24.07 ± 1.98 | 20.46 ± 1.56 | < 0.001 |
ESR (mm/h) | 54.14 ± 19.73 | 20.86 ± 6.41 | < 0.001 |
CRP (mg/L) | 27.43 ± 11.93 | 4.13 ± 3.89 | < 0.001 |
DN4 | 8.00 ± 0.96 | 1.88 ± 0.82 | < 0.001 |